Inappropriately high left ventricular mass in patients with type 2 diabetes mellitus and no overt cardiac disease. The DYDA study

Journal of Hypertension

Volumn 29, Issue 10, 2011, Pages 1994-2003

  Cioffi, Giovanni ^a,c   Faggiano, Pompilio ^b   Lucci, Donata ^c   Di Lenarda, Andrea ^d   Mureddu, Gian Francesco ^e   Tarantini, Luigi ^f   Verdecchia, Paolo ^g   Comaschi, Marco ^h   Giorda, Carlo B ⁱ   Velussi, Mario ^j   Chinali, Marcello ^k   Latini, Roberto ^l   Masson, Serge ^l   De Simone, Giovanni ^k  

^a Villa Bianca Hospital   (Italy)

^b SPEDALI CIVILI   (Italy)

^c ANMCO RESEARCH CENTER   (Italy)

^d Cardiovascular Unit   (Italy)

^e SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

^f SAN MARTINO HOSPITAL   (Italy)

^g Ospedale Assisi   (Italy)

^h UNIVERSITY OF GENOA   (Italy)

ⁱ Chieri   (Italy)

^j Diabetology Department   (Italy)

^k FEDERICO II UNIVERSITY HOSPITAL   (Italy)

^l MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

more..

Author keywords

Cardiac load; Diabetes; Hypertrophy; Inappropriate growth; Left ventricular mass

Indexed keywords

TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY HEIGHT; BODY MASS; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; INAPPROPRIATELY HIGH LEFT VENTRICULAR MASS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; SEX; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD PRESSURE; DIABETIC CARDIOMYOPATHY; ECHOGRAPHY; HEART LEFT VENTRICLE HYPERTROPHY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RISK FACTOR; STATISTICAL MODEL;

AGED; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84855990778     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32834acc6d     Document Type: Article

References (31)

1. Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, Lee ET, Welty TK, et al. Impact of diabetes on cardiac structure and function. The Strong Heart Study. Circulation 2000;101:2271-2276. (Pubitemid 30317129)
2. Cioffi G, Stefenelli C. Comparison of left ventricular geometry and left atrial size and function in patients with aortic stenosis versus those with pure aortic regurgitation. Am J Cardiol 2002;90:601-606. (Pubitemid 35264533)
3. Cioffi G, Russo TE, Stefenelli C, Selmi A, Furlanello F, Cramariuc D, et al. Severe obstructive sleep apnea elicits concentric left ventricular geometry. J Hypertens 2010;28:1074-1082.
4. de Simone G, Verdecchia P, Pede S, Gorini M, Maggioni AP. Prognosis of inappropriate left ventricular mass in hypertension: the MAVI Study. Hypertension 2002;40:470-476.
5. de Simone G, Palmieri V, Koren MJ, Mensah GA, Roman MJ, Devereux RB. Prognostic implications of the compensatory nature of left ventricular mass in arterial hypertension. J Hypertens 2001;19:119-125. (Pubitemid 32099284)
6. de Simone G, Gottdiener JS, Chinali M, Maurer MS. Left ventricular mass predicts heart failure not related to previous myocardial infarction: the Cardiovascular Health Study. Eur Heart J 2008;29:741-747. (Pubitemid 351431013)
7. Cioffi G, Faggiano P, Vizzardi E, Tarantini L, Cramariuc D, Gerdts E, de Simone G. Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis. Heart 2011;97:301-307.
8. Joshi D, Shiwalkar A, Cross MR, Sharma SK, Vachhani A, Dutt C. Continuous, noninvasive measurement of the haemodynamic response to submaximal exercise in patients with diabetes mellitus: evidence of impaired cardiac reserve and peripheral vascular response. Heart 2010;96:36-41.
9. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-458. (Pubitemid 16119719)
10. de Simone G, Devereux RB, Koren MJ, Mensah GA, Casale PN, Laragh JH. Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension. Circulation 1996;93:259-265. (Pubitemid 26031483)
11. Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echocardiographicangiographic correlations in the presence of absence of asynergy. Am J Cardiol 1976;37:7-11.
12. de Simone G, Devereux RB, Kimball TR, Mureddu GF, Roman MJ, Contaldo F, Daniels SR. Interaction between body size and cardiac workload. Influence of left ventricular mass during body growth and adulthood. Hypertension 1998;31:1077-1082. (Pubitemid 28191500)
13. Muiesan ML, de Simone G, Ganau A, Longhini C, Verdecchia P, Mancia G, Agabiti-Rosei E, Working Group on Heart and Hypertension of Italian Society of Hypertension. Inappropriate left ventricular mass: reliability and limitations of echocardiographic measurement for risk stratification and follow-up in single patients. J Hypertens 2006;24:2293-2298. (Pubitemid 44611040)
14. Mureddu GF, Cioffi G, Stefenelli C, Boccanelli A, de Simone G. Compensatory or inappropriate left ventricular mass in different models of left ventricular pressure overload: comparison between patients with aortic stenosis and arterial hypertension. J Hypertens 2009;27:642-649.
15. De Simone G, Devereux RB, Roman MJ, Alderman MH, Laragh JH. Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension 1994;23:600-606. (Pubitemid 24129354)
16. Avelar E, Cloward TV, Walker JM, Farney RJ, Strong M, Pendleton RC, et al. Left ventricular hypertrophy in severe obesity: interaction among blood pressure, nocturnal hypoxemia, body mass. Hypertension 2007;49:34-39. (Pubitemid 46360338)
17. Iacobellis G. True uncomplicated obesity is not related to increased left ventricular mass and systolic dysfunction. J Am Coll Cardiol 2004;44:2257-2258. (Pubitemid 39576053)
18. Carley AN, Severson DL. Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochim Biophys Acta 2005;1734:112-126. (Pubitemid 40724778)
19. Severson DL. Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes. Can J Physiol Pharmacol 2004;82:813-823. (Pubitemid 40223218)
20. Boudina S, Sena S, Theobald H, Sheng X, Wright JJ, Hu XX, et al. Mitochondrial energetics in the heart in obesity related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes 2007;56:2457-2466. (Pubitemid 47523253)
21. Scheuermann-Freestone M, Madsen PL, Manners D, Blamire AM, Buckingham RE, Styles P, et al. Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation 2003;107:3040-3046. (Pubitemid 36758977)
22. Hammer S, Snel M, Lamb HJ, Jazet IM, van der Meer RW, Pijl H, et al. Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function. J Am Coll Cardiol 2008;52:1006-1012.
23. Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A 2000;97:1784-1789. (Pubitemid 30118520)
24. Young ME, Guthrie PH, Razeghi P, Leighton B, Abbasi S, Patil S, et al. Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart. Diabetes 2002;51:2587-2595. (Pubitemid 34827411)
25. Legedz L, Bricca G, Lantelme P, Rial MO, Champomier P, Vincent M, Milon H. Insulin resistance and plasma triglyceride level are differently related to cardiac hypertrophy and arterial stiffening in hypertensive subjects. Vasc Health Risk Manag 2006;2:485-490. (Pubitemid 46231278)
26. Sundstrom J, Lind L, Vessby B, Andrèn B, Aro A, Lithell H. Dyslipidemia and an unfavorable fatty acid profile predict left ventricular hypertrophy 20 years later. Circulation 2001;103:836-841. (Pubitemid 32163882)
27. Schillaci G, Vaudo G, Reboldi G, Verdecchia P, Lupattelli G, Pasqualini L, et al. High-density lipoprotein cholesterol and left ventricular hypertrophy in essential hypertension. J Hypertens 2001;19:2265-2270. (Pubitemid 33135250)
28. Guida L, Celentano A, Iannuzzi R, Ferrara LA. Insulin resistance, ventricular mass and function in normoglycemic hypertensives. Nutr Metab Cardiovasc Dis 2001;11:306-311. (Pubitemid 33687819)
29. Iozzo P, Lautamaki R, Borra R, Lehto HR, Bucci M, Viljanen A, et al. Contribution of glucose tolerance and gender to cardiac adiposity. J Clin Endocrinol Metab 2009;94:4472-4482.
30. Muiesan ML, Salvetti M, Paini A, Agabiti-Rosei C, Monteduro C, Galbassini G, et al. Inappropriate left ventricular mass in patients with primary aldosteronism. Hypertension 2008;52:529-534.
31. Natal C, Fortuno A, Restituto P, Bazàn A, Colina I, Dièz J, Varo N. Cardiotrophin-1 is expressed in adipose tissue and upregulated in the metabolic syndrome. Am J Physiol Endocrinol Metab 2008;294:52-60.